Global Transdermal Drug Delivery System Market Research Report 2023(Status and Outlook)

Global Transdermal Drug Delivery System Market Research Report 2023(Status and Outlook)



Report Overview

Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as oral, topical, intravenous, intramuscular, etc. is that the patch provides a controlled release of the medication into the patient, usually through either a porous membrane covering a reservoir of medication or through body heat melting thin layers of medication embedded in the adhesive.

The Global Transdermal Drug Delivery System Market Size was estimated at USD 15060.00 million in 2022 and is projected to reach USD 36093.94 million by 2029, exhibiting a CAGR of 13.30% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Transdermal Drug Delivery System market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Transdermal Drug Delivery System Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Transdermal Drug Delivery System market in any manner.

Global Transdermal Drug Delivery System Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Hisamitsu

Mylan

GSK

Novartis

Teve (Actavis)

Johnson & Johnson

Lohmann

Teikoku Seiyaku

Bayer

Lingrui

Sanofi

Qizheng

Endo

Huarun 999

Haw Par

Nichiban

Mentholatum

Laboratoires Genevrier

Market Segmentation (by Type)

Fentanyl

Nitroglycerin

Estradiol

Nicotine

Other

Market Segmentation (by Application)

Automotive

Industrial

Others

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Transdermal Drug Delivery System Market

Overview of the regional outlook of the Transdermal Drug Delivery System Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Transdermal Drug Delivery System
1.2 Key Market Segments
1.2.1 Transdermal Drug Delivery System Segment by Type
1.2.2 Transdermal Drug Delivery System Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Transdermal Drug Delivery System Market Overview
2.1 Global Market Overview
2.1.1 Global Transdermal Drug Delivery System Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Transdermal Drug Delivery System Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Transdermal Drug Delivery System Market Competitive Landscape
3.1 Global Transdermal Drug Delivery System Sales by Manufacturers (2018-2023)
3.2 Global Transdermal Drug Delivery System Revenue Market Share by Manufacturers (2018-2023)
3.3 Transdermal Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Transdermal Drug Delivery System Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Transdermal Drug Delivery System Sales Sites, Area Served, Product Type
3.6 Transdermal Drug Delivery System Market Competitive Situation and Trends
3.6.1 Transdermal Drug Delivery System Market Concentration Rate
3.6.2 Global 5 and 10 Largest Transdermal Drug Delivery System Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Transdermal Drug Delivery System Industry Chain Analysis
4.1 Transdermal Drug Delivery System Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Transdermal Drug Delivery System Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Transdermal Drug Delivery System Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Transdermal Drug Delivery System Sales Market Share by Type (2018-2023)
6.3 Global Transdermal Drug Delivery System Market Size Market Share by Type (2018-2023)
6.4 Global Transdermal Drug Delivery System Price by Type (2018-2023)
7 Transdermal Drug Delivery System Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Transdermal Drug Delivery System Market Sales by Application (2018-2023)
7.3 Global Transdermal Drug Delivery System Market Size (M USD) by Application (2018-2023)
7.4 Global Transdermal Drug Delivery System Sales Growth Rate by Application (2018-2023)
8 Transdermal Drug Delivery System Market Segmentation by Region
8.1 Global Transdermal Drug Delivery System Sales by Region
8.1.1 Global Transdermal Drug Delivery System Sales by Region
8.1.2 Global Transdermal Drug Delivery System Sales Market Share by Region
8.2 North America
8.2.1 North America Transdermal Drug Delivery System Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Transdermal Drug Delivery System Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Transdermal Drug Delivery System Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Transdermal Drug Delivery System Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Transdermal Drug Delivery System Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Hisamitsu
9.1.1 Hisamitsu Transdermal Drug Delivery System Basic Information
9.1.2 Hisamitsu Transdermal Drug Delivery System Product Overview
9.1.3 Hisamitsu Transdermal Drug Delivery System Product Market Performance
9.1.4 Hisamitsu Business Overview
9.1.5 Hisamitsu Transdermal Drug Delivery System SWOT Analysis
9.1.6 Hisamitsu Recent Developments
9.2 Mylan
9.2.1 Mylan Transdermal Drug Delivery System Basic Information
9.2.2 Mylan Transdermal Drug Delivery System Product Overview
9.2.3 Mylan Transdermal Drug Delivery System Product Market Performance
9.2.4 Mylan Business Overview
9.2.5 Mylan Transdermal Drug Delivery System SWOT Analysis
9.2.6 Mylan Recent Developments
9.3 GSK
9.3.1 GSK Transdermal Drug Delivery System Basic Information
9.3.2 GSK Transdermal Drug Delivery System Product Overview
9.3.3 GSK Transdermal Drug Delivery System Product Market Performance
9.3.4 GSK Business Overview
9.3.5 GSK Transdermal Drug Delivery System SWOT Analysis
9.3.6 GSK Recent Developments
9.4 Novartis
9.4.1 Novartis Transdermal Drug Delivery System Basic Information
9.4.2 Novartis Transdermal Drug Delivery System Product Overview
9.4.3 Novartis Transdermal Drug Delivery System Product Market Performance
9.4.4 Novartis Business Overview
9.4.5 Novartis Transdermal Drug Delivery System SWOT Analysis
9.4.6 Novartis Recent Developments
9.5 Teve (Actavis)
9.5.1 Teve (Actavis) Transdermal Drug Delivery System Basic Information
9.5.2 Teve (Actavis) Transdermal Drug Delivery System Product Overview
9.5.3 Teve (Actavis) Transdermal Drug Delivery System Product Market Performance
9.5.4 Teve (Actavis) Business Overview
9.5.5 Teve (Actavis) Transdermal Drug Delivery System SWOT Analysis
9.5.6 Teve (Actavis) Recent Developments
9.6 Johnson andamp; Johnson
9.6.1 Johnson andamp; Johnson Transdermal Drug Delivery System Basic Information
9.6.2 Johnson andamp; Johnson Transdermal Drug Delivery System Product Overview
9.6.3 Johnson andamp; Johnson Transdermal Drug Delivery System Product Market Performance
9.6.4 Johnson andamp; Johnson Business Overview
9.6.5 Johnson andamp; Johnson Recent Developments
9.7 Lohmann
9.7.1 Lohmann Transdermal Drug Delivery System Basic Information
9.7.2 Lohmann Transdermal Drug Delivery System Product Overview
9.7.3 Lohmann Transdermal Drug Delivery System Product Market Performance
9.7.4 Lohmann Business Overview
9.7.5 Lohmann Recent Developments
9.8 Teikoku Seiyaku
9.8.1 Teikoku Seiyaku Transdermal Drug Delivery System Basic Information
9.8.2 Teikoku Seiyaku Transdermal Drug Delivery System Product Overview
9.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Product Market Performance
9.8.4 Teikoku Seiyaku Business Overview
9.8.5 Teikoku Seiyaku Recent Developments
9.9 Bayer
9.9.1 Bayer Transdermal Drug Delivery System Basic Information
9.9.2 Bayer Transdermal Drug Delivery System Product Overview
9.9.3 Bayer Transdermal Drug Delivery System Product Market Performance
9.9.4 Bayer Business Overview
9.9.5 Bayer Recent Developments
9.10 Lingrui
9.10.1 Lingrui Transdermal Drug Delivery System Basic Information
9.10.2 Lingrui Transdermal Drug Delivery System Product Overview
9.10.3 Lingrui Transdermal Drug Delivery System Product Market Performance
9.10.4 Lingrui Business Overview
9.10.5 Lingrui Recent Developments
9.11 Sanofi
9.11.1 Sanofi Transdermal Drug Delivery System Basic Information
9.11.2 Sanofi Transdermal Drug Delivery System Product Overview
9.11.3 Sanofi Transdermal Drug Delivery System Product Market Performance
9.11.4 Sanofi Business Overview
9.11.5 Sanofi Recent Developments
9.12 Qizheng
9.12.1 Qizheng Transdermal Drug Delivery System Basic Information
9.12.2 Qizheng Transdermal Drug Delivery System Product Overview
9.12.3 Qizheng Transdermal Drug Delivery System Product Market Performance
9.12.4 Qizheng Business Overview
9.12.5 Qizheng Recent Developments
9.13 Endo
9.13.1 Endo Transdermal Drug Delivery System Basic Information
9.13.2 Endo Transdermal Drug Delivery System Product Overview
9.13.3 Endo Transdermal Drug Delivery System Product Market Performance
9.13.4 Endo Business Overview
9.13.5 Endo Recent Developments
9.14 Huarun 999
9.14.1 Huarun 999 Transdermal Drug Delivery System Basic Information
9.14.2 Huarun 999 Transdermal Drug Delivery System Product Overview
9.14.3 Huarun 999 Transdermal Drug Delivery System Product Market Performance
9.14.4 Huarun 999 Business Overview
9.14.5 Huarun 999 Recent Developments
9.15 Haw Par
9.15.1 Haw Par Transdermal Drug Delivery System Basic Information
9.15.2 Haw Par Transdermal Drug Delivery System Product Overview
9.15.3 Haw Par Transdermal Drug Delivery System Product Market Performance
9.15.4 Haw Par Business Overview
9.15.5 Haw Par Recent Developments
9.16 Nichiban
9.16.1 Nichiban Transdermal Drug Delivery System Basic Information
9.16.2 Nichiban Transdermal Drug Delivery System Product Overview
9.16.3 Nichiban Transdermal Drug Delivery System Product Market Performance
9.16.4 Nichiban Business Overview
9.16.5 Nichiban Recent Developments
9.17 Mentholatum
9.17.1 Mentholatum Transdermal Drug Delivery System Basic Information
9.17.2 Mentholatum Transdermal Drug Delivery System Product Overview
9.17.3 Mentholatum Transdermal Drug Delivery System Product Market Performance
9.17.4 Mentholatum Business Overview
9.17.5 Mentholatum Recent Developments
9.18 Laboratoires Genevrier
9.18.1 Laboratoires Genevrier Transdermal Drug Delivery System Basic Information
9.18.2 Laboratoires Genevrier Transdermal Drug Delivery System Product Overview
9.18.3 Laboratoires Genevrier Transdermal Drug Delivery System Product Market Performance
9.18.4 Laboratoires Genevrier Business Overview
9.18.5 Laboratoires Genevrier Recent Developments
10 Transdermal Drug Delivery System Market Forecast by Region
10.1 Global Transdermal Drug Delivery System Market Size Forecast
10.2 Global Transdermal Drug Delivery System Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Transdermal Drug Delivery System Market Size Forecast by Country
10.2.3 Asia Pacific Transdermal Drug Delivery System Market Size Forecast by Region
10.2.4 South America Transdermal Drug Delivery System Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Transdermal Drug Delivery System by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Transdermal Drug Delivery System Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Transdermal Drug Delivery System by Type (2024-2029)
11.1.2 Global Transdermal Drug Delivery System Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Transdermal Drug Delivery System by Type (2024-2029)
11.2 Global Transdermal Drug Delivery System Market Forecast by Application (2024-2029)
11.2.1 Global Transdermal Drug Delivery System Sales (K Units) Forecast by Application
11.2.2 Global Transdermal Drug Delivery System Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings